We are live on
!
Find out more
ICM
Invenomic Capital Management Portfolio holdings
AUM
$2.18B
1-Year Est. Return
0.03%
This Fund
S&P 500
This Quarter
Est. Return
-29.17%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$122M
AUM Growth
-$127M
(-51%)
Cap. Flow
-$58.3M
Cap. Flow
% of AUM
-47.69%
Top 10 Holdings %
Top 10 Hldgs %
25.43%
Holding
188
New
64
Increased
19
Reduced
68
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
The RMR Group
RMR
|
+$4.54M |
| 2 |
InterDigital
IDCC
|
+$4.48M |
| 3 |
Stride
LRN
|
+$4.07M |
| 4 |
Strategy Inc
MSTR
|
+$2.79M |
| 5 |
Valvoline
VVV
|
+$2.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JetBlue
JBLU
|
+$6.96M |
| 2 |
SAVE
Spirit Airlines, Inc.
SAVE
|
+$5.53M |
| 3 |
Bausch Health
BHC
|
+$4.16M |
| 4 |
Raymond James Financial
RJF
|
+$4.11M |
| 5 |
Applied Industrial Technologies
AIT
|
+$3.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.23% |
| 2 | Consumer Discretionary | 15.57% |
| 3 | Industrials | 12.32% |
| 4 | Healthcare | 9.67% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Stride
LRN
$3.53B
| $4.16M | 3.4% |
+220,380
| New | +$4.07M |
|
|
AAWW
2
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $4.14M | 3.38% |
161,127
-75,198
| -32% | -$1.88M |
|
|
3
InterDigital
IDCC
$7.84B
| $3.8M | 3.11% |
+85,088
| New | +$4.48M |
|
|
4
The RMR Group
RMR
$333M
| $3.16M | 2.59% |
+117,245
| New | +$4.54M |
|
5
UGI
UGI
$7.76B
| $2.99M | 2.45% |
112,130
+33,176
| +42% | +$1.26M |
|
6
Microsoft
MSFT
$3.35T
| $2.88M | 2.35% |
18,241
-16,578
| -48% | -$2.73M |
|
7
Oracle
ORCL
$367B
| $2.85M | 2.33% |
58,963
+549
| +0.9% | +$28.3K |
|
|
8
Strategy Inc
MSTR
$35.7B
| $2.43M | 1.99% |
+205,640
| New | +$2.79M |
|
9
Nomad Foods
NOMD
$1.73B
| $2.38M | 1.95% |
+128,295
| New | +$2.5M |
|
10
PUT
iShares Russell 2000 Growth ETF
IWO
$14.4B
| $2.32M | 1.9% |
553
-43
| -7% | -$8.54K |
|
11
Cisco
CSCO
$448B
| $2.28M | 1.86% |
57,947
-17,283
| -23% | -$758K |
|
12
Prudential Financial
PRU
$42.6B
| $2.25M | 1.84% |
43,103
-5,273
| -11% | -$419K |
|
13
Ziff Davis
ZD
$1.94B
| $2.19M | 1.79% |
33,733
+3,575
| +12% | +$279K |
|
|
ACH
14
Accendra Health
ACH
$256M
| $2.17M | 1.78% |
+237,444
| New | +$1.43M |
|
15
Electronic Arts
EA
$52.9B
| $2.05M | 1.67% |
+20,438
| New | +$2.15M |
|
|
DISCK
16
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $1.96M | 1.6% |
111,827
-68,850
| -38% | -$1.78M |
|
17
eBay
EBAY
$50.4B
| $1.95M | 1.6% |
64,998
-23,527
| -27% | -$819K |
|
18
FedEx
FDX
$73B
| $1.85M | 1.52% |
15,293
+2,135
| +16% | +$301K |
|
|
19
Valvoline
VVV
$4.9B
| $1.77M | 1.45% |
+135,476
| New | +$2.6M |
|
20
Eastman Chemical
EMN
$8.01B
| $1.75M | 1.43% |
37,541
-31,485
| -46% | -$2.02M |
|
21
OR Royalties Inc
OR
$5.75B
| $1.69M | 1.38% |
227,114
-37,244
| -14% | -$331K |
|
22
Acacia Research
ACTG
$426M
| $1.63M | 1.33% |
+734,157
| New | +$1.79M |
|
23
Comcast
CMCSA
$84B
| $1.6M | 1.31% |
46,661
-39,727
| -46% | -$1.68M |
|
24
Viatris
VTRS
$20.7B
| $1.57M | 1.28% |
105,255
-23,887
| -18% | -$458K |
|
|
PARA
25
DELISTED
Paramount Global Class B
PARA
| $1.5M | 1.23% |
107,357
-2,399
| -2% | -$68.8K |
|
Similar funds
SIG
CAG
SCP
ORCP
ET
MMLI
GC
MIAS
Invenomic Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Invenomic Capital Management held 188 positions worth $122M, down 51% from $249M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Invenomic Capital Management withdrew a net $58.3M in Q1 2020, closing 36 positions and reducing 68 holdings. Its most notable exit was JetBlue, an estimated $6.96M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Invenomic Capital Management opened a new position in The RMR Group worth $3.16M.
- Invenomic Capital Management's largest Q1 2020 buy was The RMR Group: 117,245 shares worth $3.16M.
- Invenomic Capital Management added most to UGI in Q1 2020, an estimated $1.26M increase.
- Invenomic Capital Management's biggest Q1 2020 reduction was Bausch Health, cutting an estimated $4.16M.
- Invenomic Capital Management fully exited JetBlue in Q1 2020, selling an estimated $6.96M.
- Invenomic Capital Management's ten largest holdings make up 25% of its $122M portfolio in Q1 2020.
- Invenomic Capital Management opened 64 new positions and closed 36 in Q1 2020.
- Invenomic Capital Management's portfolio value fell 51% quarter-over-quarter to $122M.
Based on Invenomic Capital Management's 13F filing for Q1 2020, filed 13 May 2020.